Evoke Wealth’s Puma Biotechnology PBYI Stock Holding History

Evoke Wealth’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-223	Closed	-$1.95K	–	1295
2019 Q4	$1.95K	Hold	223	–	–	﹤0.01%	1074
2019 Q3	$2.4K	Buy	+223	New	+$2.41K	﹤0.01%	1171

Other funds holding PBYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Evoke Wealth's PBYI Position: Q1 2020 in Review

Evoke Wealth sold out of Puma Biotechnology (PBYI) in Q1 2020, closing a stake of 223 shares — an estimated $1.95K sold.

Evoke Wealth first reported a position in PBYI in Q3 2019 and held it in 2 quarters. The position peaked at $2.4K in Q3 2019. 125 funds tracked by Wall St. Rank hold PBYI as of Q1 2020.

Evoke Wealth reported no remaining Puma Biotechnology position as of Q1 2020 after selling out during the quarter.
Evoke Wealth sold 223 Puma Biotechnology shares in Q1 2020, an estimated $1.95K.
Evoke Wealth first reported a position in Puma Biotechnology in Q3 2019 and held it in 2 quarters.
Evoke Wealth's Puma Biotechnology position peaked at $2.4K in Q3 2019.
125 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.